Simons, SO;
Hurst, JR;
Miravitlles, M;
Franssen, FME;
Janssen, DJA;
Papi, A;
Duiverman, ML;
(2020)
Caring for patients with COPD and COVID-19: a viewpoint to spark discussion.
Thorax
10.1136/thoraxjnl-2020-215095.
(In press).
Preview |
Text
thoraxjnl-2020-215095.full.pdf - Published Version Download (345kB) | Preview |
Abstract
Coronavirus SARS-CoV-2 is currently causing a pandemic of COVID-19, with more than 3 million confirmed cases around the globe identified as of June 2020. During these extraordinary times, caring for patients with COVID-19 and underlying COPD poses particular challenges. Certain treatments relevant to treating patients with COPD, such as nebulised bronchodilators and non-invasive ventilation (NIV), are thought to carry an increased risk of viral spread via aerosols. Uncertainties on whether to use systemic steroids have entered the minds of intensive care and respiratory communities. Moreover, questions regarding which life-sustaining treatments to start, when to start them and even whether to start them are faced by clinicians on a daily basis. Treating COPD effectively in the context of COVID-19 is important since patients with COPD are at an increased risk of poor outcomes. Here, we summarise current viewpoints from four European countries on how to care for patients with COPD and COVID-19. We will address the following specific questions: Are patients with COPD at an increased risk of COVID-19? / Should COVID-19 be considered a COPD exacerbation? / What is the optimal medical treatment for a patient with COPD and COVID-19? / Which ventilatory support should be provided to patients with COPD and COVID-19? / What other supportive treatments should be offered to patients with COPD and COVID-19? / How should end-of-life care be delivered in patients with COPD during the COVID-19 pandemic?
Type: | Article |
---|---|
Title: | Caring for patients with COPD and COVID-19: a viewpoint to spark discussion |
Location: | England |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1136/thoraxjnl-2020-215095 |
Publisher version: | https://doi.org/10.1136/thoraxjnl-2020-215095 |
Language: | English |
Additional information: | This version is the version of record. For information on re-use, please refer to the publisher’s terms and conditions. |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Respiratory Medicine |
URI: | https://discovery.ucl.ac.uk/id/eprint/10110272 |




Archive Staff Only
![]() |
View Item |